Dual COX-2/5-LOX inhibitors from <i>Zanthoxylum simulans</i> inhibit gastric cancer cells by cross-mediating thyroid, estrogen, and oxytocin signaling pathways. This evidence concerns the gene ALOX5 and gastric cancer.